These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23551682)

  • 1. Drugs affecting the renin-angiotensin system and preservation of residual renal function in dialysis patients.
    Lang SM; Schiffl H
    Ther Apher Dial; 2013 Apr; 17(2):242-3. PubMed ID: 23551682
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of renin-angiotensin system inhibitor on residual glomerular filtration rate in hemodialysis patients.
    Itoh Y; Fujikawa T; Toya Y; Mitsuhashi H; Kobayashi N; Ohnishi T; Tamura K; Hirawa N; Yasuda G; Umemura S
    Ther Apher Dial; 2012 Dec; 16(6):554-9. PubMed ID: 23190515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of renin-angiotensin system inhibitor on residual glomerular filtration rate in hemodialysis patients.
    Itoh Y; Fujikawa T; Toya Y; Mitsuhashi H; Kobayashi N; Ohnishi T; Tamura K; Hirawa N; Yasuda G; Umemura S
    Ther Apher Dial; 2013 Apr; 17(2):243. PubMed ID: 23551683
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of Renin-Angiotensin Aldosterone System Inhibition on Serum Potassium Levels among Peritoneal Dialysis Patients.
    Ribeiro SC; Figueiredo AE; Barretti P; Pecoits-Filho R; de Moraes TP;
    Am J Nephrol; 2017; 46(2):150-155. PubMed ID: 28738355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term antihypertensive effects of aliskiren, a direct renin inhibitor, in chronic hemodialysis patients.
    Ishimitsu T; Ohta S; Ohno E; Takahashi T; Numabe A; Okamura A; Ohba S; Hashimoto A; Matsuoka H
    Ther Apher Dial; 2013 Oct; 17(5):524-31. PubMed ID: 24107281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should we prescribe blood pressure lowering drugs to every patient with advanced chronic kidney disease? A comment on two recent meta-analyses.
    Gross P; Schirutschke H; Barnett K
    Pol Arch Med Wewn; 2009 Oct; 119(10):644-7. PubMed ID: 19847140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hypertension in hemodialysis patients.
    Ram CV; Fenves AZ
    Curr Hypertens Rep; 2009 Aug; 11(4):292-8. PubMed ID: 19602331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulse pressure and inhibition of renin-angiotensin system in chronic kidney disease.
    Banerjee D; Brincat S; Gregson H; Contreras G; Streather C; Oliveira D; Nelson S
    Nephrol Dial Transplant; 2006 Apr; 21(4):975-8. PubMed ID: 16384830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with chronic kidney disease.
    Kolesnyk I; Struijk DG; Dekker FW; Krediet RT
    Neth J Med; 2010 Jan; 68(1):15-23. PubMed ID: 20103817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the renin angiotensin system in dialysis patients.
    Cravedi P; Remuzzi G; Ruggenenti P
    Semin Dial; 2011; 24(3):290-7. PubMed ID: 21682771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
    Kujal P; Chábová VČ; Vernerová Z; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Vaňourková Z; Husková Z; Opočenský M; Skaroupková P; Schejbalová S; Kramer HJ; Rakušan D; Malý J; Netuka I; Vaněčková I; Kopkan L; Cervenka L
    Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1159-69. PubMed ID: 20880190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renin inhibition and the kidney].
    Ecder T
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():28-31. PubMed ID: 20019474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which antihypertensive drugs are the most nephroprotective and why?
    Cravedi P; Ruggenenti P; Remuzzi G
    Expert Opin Pharmacother; 2010 Nov; 11(16):2651-63. PubMed ID: 20977400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-hypertensive therapy in chronic hemodialysis].
    Takabatake T
    Nihon Naika Gakkai Zasshi; 1995 Oct; 84(10):1643-7. PubMed ID: 8537717
    [No Abstract]   [Full Text] [Related]  

  • 15. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metformin should not be used by patients with reduced renal function].
    Gudmundsdottir H; Brørs O; Os I
    Tidsskr Nor Laegeforen; 2008 Apr; 128(8):936-7. PubMed ID: 18431417
    [No Abstract]   [Full Text] [Related]  

  • 17. [Renin-angiotensin-aldosterone system in chronic renal failure].
    Matsuzaki K; Kinouchi T; Koide K; Shimizu N
    Nihon Rinsho; 1992 Jan; 50 Suppl():573-9. PubMed ID: 1578740
    [No Abstract]   [Full Text] [Related]  

  • 18. The renin-angiotensin-aldosterone system during haemodialysis with acetate or bicarbonate at different dialysate sodium concentrations.
    Krämer BK; Ress KM; Ulshöfer TM; Risler T
    Nephrol Dial Transplant; 1987; 2(6):531-6. PubMed ID: 3126454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A 100-year perspective on renal function and hypertension. Anti-renin therapy has made hypertensive renal failure a rarity].
    Bergström G; Herlitz H; Himmelmann A; Ljungman S; Aurell M
    Lakartidningen; 1999 Nov; 96(47):5209-14. PubMed ID: 10608112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-angiotensin-aldosterone system in patients on maintenance hemodialysis.
    Ivić M; Strahinjić S; Stefanović V
    Acta Med Iugosl; 1987; 41(3):205-13. PubMed ID: 3661237
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.